AZZAD ASSET MANAGEMENT INC /ADV
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1121914
FALLS CHURCH, VA
Position in HALO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$972,426
+$204,364 QoQ
Shares Held
12,424
+4.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#313
of 664 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. HALO ranks #4 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,630 | $1,393,768 | |
| 2 | INCY |
Incyte Corp
|
9,067 | $1,027,835 | |
| 3 | TECH |
BIO-TECHNE Corp
|
14,008 | $989,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
12,424 | $972,426 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
984 | $613,563 | |
| 6 | EXEL |
Exelixis, Inc.
|
7,911 | $430,437 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
4,784 | $379,323 |
All Filings in HALO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $972,426 | 12,424 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $768,062 | 11,884 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $815,743 | 12,121 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $874,946 | 11,930 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||